Back
ESC Premium Access

Impacts of hemoglobin levels and platelet counts on clinical outcomes in patients with atrial fibrillation: oral anticoagulant use for patients with anemia and/or thrombocytopenia

Session: Atrial fibrillation e-posters
Topic: Oral Anticoagulation
Speaker: Doctor T. Chao (Taipei, TW)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)
2 presentations
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Access
Abstract
Slides
Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Access
Abstract
Slides
Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Access
Abstract
Slides
Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Doctor T. Chao, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Access
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

COVID-19 and ACS admissions: lessons from the UK.

27 August 2021

ESC Premium Access

Net clinical benefit of direct oral anticoagulants in very elderly and high bleeding risk patients with atrial fibrillation who are often excluded from oral anticoagulation therapy: a nationwide popul

27 August 2021

ESC Premium Access

Clinical benefit of direct oral anticoagulants vs. vitamin-K antagonist in octogenarians with atrial fibrillation

27 August 2021

ESC 365 is supported by

logo Novo Nordisk